Regulation 2023/1182 - Specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
Contents
official title
Regulation (EU) 2023/1182 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland and amending Directive 2001/83/ECLegal instrument | Regulation |
---|---|
Number legal act | Regulation 2023/1182 |
Original proposal | COM(2023)122 |
CELEX number i | 32023R1182 |
Document | 14-06-2023; Date of signature |
---|---|
Publication in Official Journal | 20-06-2023; OJ L 157 p. 1-7 |
Signature | 14-06-2023 |
Effect | 21-06-2023; Entry into force Date pub. +1 See Art 14 01-01-2025; Application See Art 14 And 52024XC07473 |
End of validity | 31-12-9999 |
This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.
This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.